Oral contraceptives and colorectal cancer

Digestive and Liver Disease

Volumn 35, Issue 2, 2003, Pages 85-87

  Levi, F ^a   Pasche, C ^a   Lucchini, F ^a   La Vecchia, C ^b,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Colorectal cancer; Oral contraceptives

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIET; DISEASE DURATION; FEMALE; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ORAL CONTRACEPTION; RISK ASSESSMENT; SWITZERLAND; ADULT; AGED; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; MIDDLE AGED; RISK; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 0041766198     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00004-5     Document Type: Article

References (21)

1. Fraumeni JF, Lloyd JW, Smith EM, et al. Cancer mortality among nuns; role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst 1969;42:455-68.
2. Herbert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998;7:653-9.
3. IARC. Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 72, Hormonal Contraception and Post-Menopausal Hormonal Therapy. Lyon: International Agency for Research on Cancer, 1999
4. La Vecchia C, Brinton A, McTiernan A. Menopause, hormone replacement therapy and cancer. Maturitas 2001;39:97-115.
5. Fernandez E, La Vecchia C, Balducci A, et al. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001;84:722-7.
6. Beral V, Hermon C, Kay C, et al. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46000 women from Royal College of General Practitioners' oral contraception study. Br Med J 1999;318:96-100.
7. Fernandez E, La Vecchia C, Franceschi S, et al. Oral contraceptive use and risk of colorectal cancer. Epidemiology 1998;9:295-300.
8. La Vecchia C, Altieri A, Franceschi S, Tavani A. Oral contraceptives and cancer. An update. Drug Safety 2001;24:741-54.
9. Levi F, Pasche C, Lucchini F, La Vecchia C. Macronutrients and colorectal cancer: a Swiss case-control study. Ann Oncol 2002;13:369-73.
10. Kuntz J, Bitzer J. Pregnancy prevention from the viewpoint of women: patient counseling by the general practitioner is rated as "very good". Women assess the pill as an effective and safe contraception method. A representative survey. Schweiz Med Prax 2000;89:1142-6.
11. La Vecchia C. Reducing colorectal cancer through faecal occult blood screening. Review of the evidence. Dig Liver Dis 2001;33:445-8.
12. Bosetti C, Tavani A, Negri E, Trichopoulos D, La Vecchia C. Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol 2001;54:902-6.
13. McMichael AJ, Potter J. Host factors in carcinogenesis: certain bile-acid metabolism profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985;75:185-91.
14. Lointier P, Wildrick DM, Boman BM. The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 1992;12:1327-30.
15. Thomas ML, Xu X, Norfleet AM, et al. The presence of functional estrogen receptors in intestinal epithelial cells. Endocrinology 1993;132:426-30.
16. Issa JP, Ottaviano YL, Celano P, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-40.
17. Campagnoli C, Biglia N, Cantamessa C, et al. Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I values. Gynecol Endocrinol 1998;12:259-66.
18. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami HO, Mantroros C. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999;83:15-7.
19. Giovannucci E, Pollak MN, Platz EA, et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000;9:345-9.
20. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002;94:972-80.
21. Fernandez E, Bosetti C, La Vecchia C, Levi F, Fioretti F, Negri E. Sex differences in colorectal cancer mortality in Europe, 1955-1996. Eur J Cancer Prev 2000;9:99-104.